TABLE 3

Summary of pharmacokinetic estimates of pitavastatin and rosuvastatin in the presence of single ascending doses of rifampicin in cynomolgus monkey

Control+Rifampicin 1 mg/kg+Rifampicin 3 mg/kg+Rifampicin 10 mg/kg+Rifampicin 30 mg/kg
Mean ± S.D.Mean ± S.D.Mean ± S.D.Mean ± S.D.Mean ± S.D.
Pitavastatin
CL (ml/min/kg)18.0 ± 4.615.0 ± 2.57.5 ± 2.04.9 ± 1.34.3 ± 1.6
  Fold change0.830.42**0.27**0.24**
Vdss (l/kg)1.79 ± 0.721.97 ± 0.500.47 ± 0.200.52 ± 0.160.55 ± 0.20
  Fold change1.100.26**0.29**0.30**
t1/2 (h)5.9 ± 0.97.2 ± 1.72.9 ± 1.93.8 ± 0.74.5 ± 0.6
  Fold change1.210.50**0.630.76
Oral AUClast (ng.h/ml)299 ± 146515 ± 4172690 ± 27104070 ± 43575808 ± 4579
  Fold change1.728.99**13.60**19.41**
Oral Cmax (ng/ml)225 ± 200520 ± 8222730 ± 20401920 ± 29502780 ± 3166
  Fold change2.3112.13**8.53**12.36**
Rosuvastatin
CL (ml/min/kg)27.5 ± 7.823.6 ± 2.420.0 ± 2.115.6 ± 1.913.4 ± 3.7
  Fold change0.860.730.57**0.49**
Vdss (l/kg)0.67 ± 0.410.61 ± 0.060.64 ± 0.160.71 ± 0.080.79 ± 0.16
  Fold change0.910.961.051.17
t1/2 (h)2.5 ± 0.72.5 ± 0.82.1 ± 0.33.1 ± 0.14.8 ± 2.0
  Fold change1.010.861.231.93*
Oral AUClast (ng.h/ml)49 ± 1263 ± 28232 ± 43467 ± 267744 ± 512
  Fold change1.284.68**9.41**15.01**
Oral Cmax (ng/ml)15 ± 1124 ± 29122 ± 46150 ± 100227 ± 169
  Fold change1.547.72**9.49**14.37**
Rifampicin
Oral AUClast (ng.h/ml)985 ± 39611,300 ± 326070,100 ± 10,800240,000 ± 73,900
 Dose-normalized change related to 1 mg/kg3.87.18.1
Oral Cmax (ng/ml)176 ± 992050 ± 2457980 ± 248024,200 ± 14,100
 Dose-normalized change related to 1 mg/kg3.84.54.6
  • Data represent mean ± S.D. (N = 4). One-way analysis of variance with Dunnett’s multiple comparisons test was employed to test significance with *p < 0.05; **p < 0.01.